Oscient Pharmaceuticals (Antara Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Oscient Pharmaceuticals (Antara Drug) General Information

Description

A cholesterol-lowering medicine. The drug is engaged in lowering the cholesterol level in patients. It has the generic name fenofibrate.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 1000 Winter Street
  • Suite 2200
  • Waltham, MA 02451
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oscient Pharmaceuticals (Antara Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request a free trial

Oscient Pharmaceuticals (Antara Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request a free trial

Oscient Pharmaceuticals (Antara Drug) FAQs

  • Where is Oscient Pharmaceuticals (Antara Drug) headquartered?

    Oscient Pharmaceuticals (Antara Drug) is headquartered in Waltham, MA.

  • What industry is Oscient Pharmaceuticals (Antara Drug) in?

    Oscient Pharmaceuticals (Antara Drug)’s primary industry is Buildings and Property.

  • Is Oscient Pharmaceuticals (Antara Drug) a private or public company?

    Oscient Pharmaceuticals (Antara Drug) is a Private company.

  • What is the current valuation of Oscient Pharmaceuticals (Antara Drug)?

    The current valuation of Oscient Pharmaceuticals (Antara Drug) is 000.00.

  • What is Oscient Pharmaceuticals (Antara Drug)’s current revenue?

    The current revenue for Oscient Pharmaceuticals (Antara Drug) is 000000.

  • Who are Oscient Pharmaceuticals (Antara Drug)’s investors?

    Ethypharm and Oscient Pharmaceuticals have invested in Oscient Pharmaceuticals (Antara Drug).

  • When was Oscient Pharmaceuticals (Antara Drug) acquired?

    Oscient Pharmaceuticals (Antara Drug) was acquired on 25-Sep-2009.

  • Who acquired Oscient Pharmaceuticals (Antara Drug)?

    Oscient Pharmaceuticals (Antara Drug) was acquired by Lupin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »